Jade Biosciences Inc.
JBIO | NASDAQ
$13.70
-$0.36 (-2.56%)
Nov 2, 2026, 11:28 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 9K | 9K | n/a | n/a | n/a | 4K | 8K | n/a | 28K | 28K | 28K | 25K |
Gross Profit | -9K | -9K | n/a | n/a | n/a | -4K | -8K | n/a | -28K | -28K | -28K | -25K |
Operating Income | -58.92M | -43.45M | -34.98M | -27.4M | -27.78M | -3.39M | -6.4M | -14.97M | -26.17M | -24.62M | -22.07M | -21.37M |
Interest Income | 3.23M | 3.1M | 3.09M | 2.25M | 1.83M | 871K | 1.03M | 388K | 1.4M | 1.44M | 1.71M | 1.8M |
Pretax Income | -55.75M | -40.35M | -31.87M | -25.18M | -32.13M | -2.52M | -5.38M | -16.28M | -24.78M | -23.19M | -20.36M | -19.56M |
Net Income | -55.77M | -40.37M | -31.93M | -25.18M | -32.13M | -2.52M | -5.43M | -16.28M | -24.78M | -23.19M | -20.41M | -19.56M |
Selling & General & Admin | 8.84M | 7.38M | 6.44M | 5.39M | 5.23M | 3.38M | 4.86M | 1.38M | 4.89M | 4.51M | 4.23M | 4.46M |
Research & Development | 50.07M | 36.05M | 28.54M | 22.01M | 22.55M | n/a | 1.53M | 13.58M | 21.25M | 20.08M | 17.81M | 16.88M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 58.91M | 43.44M | 34.98M | 27.4M | 27.78M | 3.38M | 6.4M | 14.97M | 26.14M | 24.59M | 22.04M | 21.34M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | 100K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 58.92M | 43.45M | 34.98M | 27.4M | 27.78M | 3.39M | 6.4M | 14.97M | 26.17M | 24.62M | 22.07M | 21.37M |
Income Tax Expense | 15K | 16K | 58K | n/a | n/a | n/a | 55K | n/a | n/a | n/a | 56K | n/a |
Shares Outstanding (Basic) | 61.05M | 57.78M | 49.32M | 39.58M | 28.43M | 828.14K | 828.14K | 3.16M | 821.6K | 794.17K | 791.29K | 789.73K |
Shares Outstanding (Diluted) | 61.05M | 57.78M | 49.32M | 39.58M | 28.43M | 828.14K | 828.14K | 3.16M | 821.6K | 794.17K | 791.29K | 789.73K |
EPS (Basic) | -0.76 | -0.70 | -0.65 | -0.64 | -1.13 | -3.04 | -6.56 | -5.16 | -30.15 | -29.20 | -25.80 | -24.77 |
EPS (Diluted) | -0.76 | -0.70 | -0.65 | -0.64 | -1.13 | -3.04 | -6.56 | -5.16 | -30.15 | -29.20 | -25.80 | -24.77 |
EBITDA | -58.91M | -40.34M | -31.87M | -25.16M | -32.13M | -2.51M | -5.37M | -16.28M | -24.75M | -23.16M | -20.33M | -19.54M |
EBIT | -58.92M | -40.35M | -31.87M | -25.18M | -32.13M | -2.52M | -5.38M | -16.28M | -24.78M | -23.19M | -20.36M | -19.56M |
Depreciation & Amortization | 9K | 9K | 9K | 12K | 1K | 4K | 8K | n/a | 28K | 28K | 28K | 25K |
Add to Watchlist
Select watchlists to add or remove JBIO